1. Home
  2. TOVX vs VEON Comparison

TOVX vs VEON Comparison

Compare TOVX & VEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TOVX
  • VEON
  • Stock Information
  • Founded
  • TOVX 2001
  • VEON 1992
  • Country
  • TOVX United States
  • VEON United Arab Emirates
  • Employees
  • TOVX N/A
  • VEON N/A
  • Industry
  • TOVX Biotechnology: Pharmaceutical Preparations
  • VEON Telecommunications Equipment
  • Sector
  • TOVX Health Care
  • VEON Telecommunications
  • Exchange
  • TOVX Nasdaq
  • VEON Nasdaq
  • Market Cap
  • TOVX 4.5M
  • VEON 3.8B
  • IPO Year
  • TOVX 2006
  • VEON 1996
  • Fundamental
  • Price
  • TOVX $0.41
  • VEON $52.20
  • Analyst Decision
  • TOVX Hold
  • VEON Strong Buy
  • Analyst Count
  • TOVX 1
  • VEON 1
  • Target Price
  • TOVX N/A
  • VEON $60.00
  • AVG Volume (30 Days)
  • TOVX 359.6K
  • VEON 197.1K
  • Earning Date
  • TOVX 11-11-2025
  • VEON 11-13-2025
  • Dividend Yield
  • TOVX N/A
  • VEON N/A
  • EPS Growth
  • TOVX N/A
  • VEON N/A
  • EPS
  • TOVX N/A
  • VEON 13.63
  • Revenue
  • TOVX N/A
  • VEON $4,148,000,000.00
  • Revenue This Year
  • TOVX N/A
  • VEON $10.26
  • Revenue Next Year
  • TOVX N/A
  • VEON $7.02
  • P/E Ratio
  • TOVX N/A
  • VEON $3.86
  • Revenue Growth
  • TOVX N/A
  • VEON 7.27
  • 52 Week Low
  • TOVX $0.37
  • VEON $27.95
  • 52 Week High
  • TOVX $4.20
  • VEON $64.00
  • Technical
  • Relative Strength Index (RSI)
  • TOVX 47.72
  • VEON 43.26
  • Support Level
  • TOVX $0.38
  • VEON $50.00
  • Resistance Level
  • TOVX $0.45
  • VEON $55.06
  • Average True Range (ATR)
  • TOVX 0.02
  • VEON 2.78
  • MACD
  • TOVX 0.00
  • VEON -0.66
  • Stochastic Oscillator
  • TOVX 49.14
  • VEON 16.55

About TOVX Theriva Biologics Inc.

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.

About VEON VEON Ltd. ADS

VEON Ltd is a United Arab Emirates-based digital operator providing connectivity and Internet services to corporations and individuals. The company offers mobile and fixed-line telecommunications services through a range of traditional and broadband mobile technologies. The company's reportable segments consist of the following five segments: Pakistan, Ukraine, Kazakhstan, Bangladesh, and Uzbekistan. It provides its services under the Beeline, Kyivstar, Banglalink, and Jazz brands. It generates the majority of its revenue from Pakistan.

Share on Social Networks: